首页> 外文OA文献 >1012-121 Lack of heart rate effects on the mortality benefits of carvedilol compared to metoprolol in the patients with heart failure: Results from the carvedilol or metoprolol European trial (COMET)

【2h】

1012-121 Lack of heart rate effects on the mortality benefits of carvedilol compared to metoprolol in the patients with heart failure: Results from the carvedilol or metoprolol European trial (COMET)

机译：1012-121心力衰竭患者与美托洛尔相比，心率缺乏对卡维地洛死亡率益处的影响：卡维地洛或美托洛尔欧洲试验（COMET）的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Metra Marco; Cleland John G; Di Lenarda Andrea; Hanrath Peter; Komajda Michel; Lutiger Beatrix; Poole-Wilson Philip A; Remme Willem J; Scherhag Armin; Charlesworth Andrew; Swedberg Karl; Torp-Pedersen Christian;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET). [J] . Cleland JG, Charlesworth A, Lubsen J, Journal of the American College of Cardiology . 2006,第8期

机译：卡维地洛和美托洛尔对心力衰竭患者的幸福感，发病率和死亡率（“患者旅程”）的影响比较：来自卡维地洛或美托洛尔欧洲试验（COMET）的报告。
2. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) [J] . Christian Torp-Pedersen, Marco Metra, Andrew Charlesworth, Heart . 2007,第8期

机译：美托洛尔和卡维地洛对慢性心力衰竭患者先前和新发糖尿病的影响：来自卡维地洛或美托洛尔欧洲试验（COMET）的数据
3. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. [J] . Poole-Wilson PA, Swedberg K, Cleland JG, The Lancet . 2003,第9377期

机译：卡维地洛或美托洛尔欧洲试验（COMET）中卡维地洛和美托洛尔对慢性心力衰竭患者临床结局的比较：随机对照试验。
4. Analysis on the Treatment of Trimetazidine Jointed with Metoprolol in the Coronary Heart Disease with the Heart Failure [C] . Lingdong Meng, Yuntao Cheng International Forum on Bioinformatics and Medical Engineering . 2015

机译：用心力衰竭冠心病中甲状腺腈治疗三嗪治疗的分析
5. Factors associated with adherence in heart failure. A secondary analysis of a large clinical trial: Candesartan in Heart failure -Assessment of Reduction in Mortality and Morbidity (CHARM) [D] . Granger, Bradi B. 2004

机译：与心力衰竭依从性相关的因素。大型临床试验的次要分析：坎地沙坦治疗心力衰竭-死亡率和发病率降低的评估（CHARM）
6. Effects of metoprolol and carvedilol on pre‐existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) [O] . Christian Torp‐Pedersen, Marco Metra, Andrew Charlesworth, 2007

机译：美托洛尔和卡维地洛对慢性心力衰竭患者先前和新发糖尿病的影响：来自卡维地洛或美托洛尔欧洲试验（COMET）的数据
7. A Comparison of the Effects of Carvedilol and Metoprolol on Well-Being, Morbidity, and Mortality (the “Patient Journey”) in Patients With Heart Failure A Report From the Carvedilol Or Metoprolol European Trial (COMET) [O] . Cleland John G.F., Charlesworth Andrew, Lubsen Jacobus, 2006

机译：卡维地洛和美托洛尔对心力衰竭患者的幸福感，发病率和死亡率（“患者旅程”）影响的比较-卡维地洛或美托洛尔欧洲试验（COMET）的报告

1012-121 Lack of heart rate effects on the mortality benefits of carvedilol compared to metoprolol in the patients with heart failure: Results from the carvedilol or metoprolol European trial (COMET)

著录项

相似文献

相关主题

期刊订阅